1. Home
  2. WK vs IOVA Comparison

WK vs IOVA Comparison

Compare WK & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WK
  • IOVA
  • Stock Information
  • Founded
  • WK 2008
  • IOVA 2007
  • Country
  • WK United States
  • IOVA United States
  • Employees
  • WK N/A
  • IOVA N/A
  • Industry
  • WK Computer Software: Prepackaged Software
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • WK Technology
  • IOVA Health Care
  • Exchange
  • WK Nasdaq
  • IOVA Nasdaq
  • Market Cap
  • WK 4.3B
  • IOVA 3.6B
  • IPO Year
  • WK 2014
  • IOVA N/A
  • Fundamental
  • Price
  • WK $71.43
  • IOVA $9.29
  • Analyst Decision
  • WK Buy
  • IOVA Strong Buy
  • Analyst Count
  • WK 5
  • IOVA 10
  • Target Price
  • WK $95.00
  • IOVA $24.80
  • AVG Volume (30 Days)
  • WK 342.1K
  • IOVA 6.3M
  • Earning Date
  • WK 10-28-2024
  • IOVA 11-05-2024
  • Dividend Yield
  • WK N/A
  • IOVA N/A
  • EPS Growth
  • WK N/A
  • IOVA N/A
  • EPS
  • WK N/A
  • IOVA N/A
  • Revenue
  • WK $677,998,000.00
  • IOVA $32,772,000.00
  • Revenue This Year
  • WK $19.03
  • IOVA $13,836.92
  • Revenue Next Year
  • WK $15.50
  • IOVA $183.20
  • P/E Ratio
  • WK N/A
  • IOVA N/A
  • Revenue Growth
  • WK 16.52
  • IOVA 13669.75
  • 52 Week Low
  • WK $65.47
  • IOVA $3.21
  • 52 Week High
  • WK $116.00
  • IOVA $18.33
  • Technical
  • Relative Strength Index (RSI)
  • WK 37.99
  • IOVA 39.99
  • Support Level
  • WK $69.42
  • IOVA $8.80
  • Resistance Level
  • WK $75.71
  • IOVA $11.80
  • Average True Range (ATR)
  • WK 2.04
  • IOVA 0.62
  • MACD
  • WK -0.92
  • IOVA -0.33
  • Stochastic Oscillator
  • WK 16.68
  • IOVA 12.18

About WK Workiva Inc.

Workiva Inc is a cloud-native platform that simplifies the complexities of reporting and compliance. Workiva platform empowers customers by connecting and transforming data from hundreds of enterprise resource planning (ERP), human capital management (HCM), and customer relationship management (CRM) systems, as well as other third-party cloud and on-premise applications. Customers use the platform to create, review and publish data-linked documents and reports with greater control, consistency, accuracy, and productivity and it is also used for SEC Filings. It provides to more than 6,000 organizations across the globe with SaaS platform solutions to help solve some of the most complex reporting and disclosure challenges.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

Share on Social Networks: